Blogger: Dan Blum
I was reviewing a product profile for a small anti-malware vendor with our analyst team, and received the following question:
“In the analysis of the product, you only mention its lack of host intrusion prevention software (HIPS) as a gap, but not its lack of a vulnerability management product. What components need to be part of core endpoint security functionality?”
At this point I’m evaluating endpoint anti-malware suites as follows: While customers may not deploy all these features, the vendor should be able to offer anti-virus, anti-spyware, web threat protection, mailbox/mail scan, system firewall, NIPS, HIPS, NAC, and application control on the endpoint – all with unified administrator-minimizing management, broad platform support, easy migration from previous releases, good end user experience, modularity, affordable pricing and good industry test results.
Symantec and McAfee, as the market leaders, provide benchmarks against which other vendors in the anti-malware space can be compared. The Big Two are broadening “endpoint protection” to include data leakage protection (DLP) and host encryption in their product lines. But it will take some time for McAfee and even longer for Symantec to move the acquired products into the single agent/single console architecture they both tout for their endpoint anti-malware components. Both also have host-based vulnerability management (scanning, remediation, patching), but only McAfee has integrated vulnerability management with its ePO manager software. Both vendors will price vulnerability management, DLP, and encryption separately from anti-malware for the indefinite future.
The real benchmark is: What do the customers want? In my experience large enterprise customers are generally on a vendor diet, trying to get from tens of security vendors to lower numbers, but not to one.
I don’t see great urgency on customers’ part to subsume endpoint anti-malware into a larger endpoint protection suite. However, the vendor diet (consolidation) might lead some to choose the larger suite vendor over the niche vendor if the large vendor is equal or close to equal in price, performance, and functionality.
Smaller vendors such as Trend Micro, Kaspersky, Sophos or Panda Software that are chasing Symantec and McAfee market share in the anti-malware races, might have a fairly complete anti-malware suite but lack any or all of DLP, host encryption, and vulnerability management. But because Symantec and McAfee haven’t yet integrated anti-malware with all their other endpoint security functions (let alone merged the pricing), I don’t consider the lack of offerings beyond anti-malware a weakness for the smaller vendors. But it is something to keep an eye on, as the security suites have a way of expanding.
Comments